4.4 Article

Challenging the holy grail of hospital accreditation: A cross sectional study of inpatient satisfaction in the field of cardiology

Journal

BMC HEALTH SERVICES RESEARCH
Volume 10, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1472-6963-10-120

Keywords

-

Ask authors/readers for more resources

Background: Subjective parameters such as quality of life or patient satisfaction gain importance as outcome parameters and benchmarks in health care. In many countries hospitals are now undergoing accreditation as mandatory or voluntary measures. It is believed but unproven that accreditations positively influence quality of care and patient satisfaction. The present study aims to assess in a defined specialty (cardiology) the relationship between patient satisfaction (as measured by the recommendation rate) and accreditation status. Methods: Consecutive patients discharged from 25 cardiology units received a validated patient satisfaction questionnaire. Data from 3,037 patients (response rate > 55%) became available for analysis. Recommendation rate was used as primary endpoint. Different control variables such as staffing level were considered. Results: The 15 accredited units did not differ significantly from the 10 non-accredited units regarding main hospital (i.e. staffing levels, no. of beds) and patient (age, gender) characteristics. The primary endpoint recommendation rate of a given hospital for accredited hospitals (65.6%, 95% Confidence Interval (CI) 63.4-67.8%) and hospitals without accreditation (65.8%, 95% CI 63.1-68.5%) was not significantly different. Conclusion: Our results support the notion that - at least in the field of cardiology - successful accreditation is not linked with measurable better quality of care as perceived by the patient and reflected by the recommendation rate of a given institution. Hospital accreditation may represent a step towards quality management, but does not seem to improve overall patient satisfaction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Overlap of heartburn, functional dyspepsia, and irritable bowel syndrome in a population sample: Prevalence, temporal stability, and associated comorbidities

Michael P. Jones, Ayesha Shah, Marjorie M. Walker, Natasha A. Koloski, Gerald Holtmann, Nicholas J. Talley

Summary: This study found that there is an overlap between irritable bowel syndrome (IBS), functional dyspepsia (FD), and heartburn (GERD), which is considered as a distinct entity with features of psychological morbidity, sleep disturbance, and elevated rates of atopy.

NEUROGASTROENTEROLOGY AND MOTILITY (2022)

Article Medicine, Research & Experimental

Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial

Mengli Xiao, Linda L. D. Zhong, Wai Ching Lam, Yingpan Zhao, Kok-Ann Gwee, Gerald Holtmann, Jan Tack, Hidekazu Suzuki, Min-Hu Chen, Yinglian Xiao, Xiaohua Hou, Jinsong Liu, Yang Li, Xu-Dong Tang, Fang Lu

Summary: This study aims to provide further evidence on the clinical efficacy and safety of ZZKZ in treating patients with FD-PDS. By comparing the effects of ZZKZ with a placebo group over a double-blind treatment period of 8 weeks, the study aims to investigate the long-term medication effect.

TRIALS (2022)

Article Gastroenterology & Hepatology

Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia

Erin R. Shanahan, Seungha Kang, Heidi Staudacher, Ayesha Shah, Anh Do, Grace Burns, Veronique S. Chachay, Natasha A. Koloski, Simon Keely, Marjorie M. Walker, Nicholas J. Talley, Mark Morrison, Gerald J. Holtmann

Summary: This study indicates a link between duodenal microbiota, gastric emptying, and FD symptoms, and this link is largely independent of long-term dietary intake.
Review Gastroenterology & Hepatology

Asia-Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms

Kok-Ann Gwee, Yeong Yeh Lee, Hidekazu Suzuki, Uday Chand Ghoshal, Gerald Holtmann, Tao Bai, Giovanni Barbara, Min-hu Chen, Andrew Seng Boon Chua, Peter R. Gibson, Xiaohua Hou, Jinsong Liu, Atsushi Nakajima, Nitesh Pratap, Sanjeev Sachdeva, Kewin Tien Ho Siah, Alex Yu Sen Soh, Kentaro Sugano, Jan Tack, Victoria Ping Yi Tan, Xudong Tang, Marjorie Walker, Deng-Chyang Wu, Ying-Lian Xiao, Khairil Khuzaini Zulkifli, Clarissa Toh

Summary: Contemporary systems categorize patients into sub-classes based on symptoms to enable targeted treatment, but overlapping symptom categories negatively impact outcomes, lacking guidance on management. An APAGE working group developed clinical practice guidelines for management of patients with functional dyspepsia (FD) who have overlaps with other functional gastrointestinal disorders. They identified putative pathophysiology and provided a management algorithm for primary and secondary care clinicians.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Diabetes mellitus is an independent risk factor for a greater frequency of early satiation and diarrhea at one and three years: Two prospective longitudinal population-based studies

Natasha A. Koloski, Michael Jones, Marjorie M. Walker, Michael Horowitz, Gerald Holtmann, Nicholas J. Talley

Summary: Diabetes is an independent risk factor for an increased frequency of gastrointestinal symptoms, adjusting for lifestyle and psychological factors.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Letter Gastroenterology & Hepatology

Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis

Ahmad H. Ali, Cynthia W. Buness, Ryan Fischer, Gerald J. Holtmann, Ayesha Shah, Peter Lewindon, Shamita Shah, Amol S. Ragnekar, Amy E. Taylor, Aparna Goel, Kenneth L. Cox, Leina Alrabadi, Steve Wadsworth, Sakil S. Kulkarni, Keith D. Lindor

HEPATOLOGY (2023)

Review Gastroenterology & Hepatology

Placebo effects in functional dyspepsia: Causes and implications for clinical trials

Michael P. Jones, Gerald Holtmann

Summary: Placebo responses provide insights into mechanisms beyond the intervention and affect the potential efficacy of new interventions in clinical trials. This mini-review discusses the systematic review and meta-analysis conducted by Bosman and colleagues on placebo response in functional dyspepsia clinical trials. It also explores potential mechanisms of placebo response in the context of brain-gut interaction disorders and extra-gastrointestinal disorders.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Immunology

Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia

Grace L. Burns, Jessica K. Bruce, Kyra Minahan, Andrea Mathe, Thomas Fairlie, Raquel Cameron, Crystal Naudin, Prema M. Nair, Michael D. E. Potter, Mudar Zand Irani, Steven Bollipo, Robert Foster, Lay T. T. Gan, Ayesha Shah, Natasha A. Koloski, Paul S. Foster, Jay C. Horvat, Martin Veysey, Gerald Holtmann, Nick Powell, Marjorie M. Walker, Nicholas J. Talley, Simon Keely

Summary: This study found that patients with functional dyspepsia have increased Th2 and Th17 lymphocyte populations in the duodenal mucosa, and these cells are of effector and memory phenotype, indicating that the microinflammation in functional dyspepsia may be antigen-driven.

FRONTIERS IN IMMUNOLOGY (2023)

Review Gastroenterology & Hepatology

Unravelling the controversy with small intestinal bacterial overgrowth

Ayesha Shah, Uday C. Ghoshal, Gerald J. Holtmann

Summary: The aim of this review is to summarize the current and emergent approaches to characterize the small intestinal microbiota and discuss the treatment options for management of small intestinal bacterial overgrowth (SIBO). This review captures the growing body of evidence for the role of SIBO, a type of small intestinal dysbiosis in the pathophysiology various gastrointestinal and extraintestinal disorders. Although recurrence is common, targeted modulation of the gut microbiome as a therapeutic option for management of SIBO is associated with improvement in symptoms and quality of life.

CURRENT OPINION IN GASTROENTEROLOGY (2023)

Review Gastroenterology & Hepatology

Upper GI endoscopy in subjects with positive fecal occult blood test undergoing colonoscopy: systematic review and meta-analysis

Ayesha Shah, Ali Eqbal, Naomi Moy, Natasha Koloski, Helmut Messmann, Bradley J. Kendall, Prateek Sharma, Uwe Dulleck, Michael P. Jones, Gerald J. Holtmann

Summary: This study aimed to determine the prevalence of upper gastrointestinal (UGI) lesions in subjects with a positive fecal occult blood test (FOBT+). The results showed that the prevalence of UGI cancers in FOBT+ subjects was 0.8%, and the prevalence of UGI clinically significant lesions (CSLs) was 30.4%. Anemia was associated with UGI cancers and UGI CSLs, while gastrointestinal symptoms were not associated with UGI CSLs.

GASTROINTESTINAL ENDOSCOPY (2023)

Review Gastroenterology & Hepatology

Evaluation of small intestinal bacterial overgrowth

Uday C. Ghoshal, Ujjala Ghoshal, Ayesha Shah, Gerald Holtmann

Summary: There is a significant interest in gut microbiota dysbiosis, specifically small intestinal bacterial overgrowth (SIBO), however, the current diagnostic methods for SIBO are not satisfactory. This review discusses the different invasive and noninvasive tests for diagnosing SIBO, their methodology, interpretation, sensitivity, specificity, and limitations. It also presents potential methods for diagnosis of SIBO that may be useful in clinical practice in the future.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2023)

Review Gastroenterology & Hepatology

Small Intestinal Bacterial Overgrowth Complicating Gastrointestinal Manifestations of Systemic Sclerosis: A Systematic Review and Meta-analysis

Ayesha Shah, Veenaa Pakeerathan, Michael P. Jones, Purna C. Kashyap, Kate Virgo, Thomas Fairlie, Mark Morrison, Uday C. Ghoshal, Gerald J. Holtmann

Summary: This systematic review and meta-analysis investigated the prevalence of small intestinal bacterial overgrowth (SIBO) in systemic sclerosis (SSc), as well as the risk factors and the effects on gastrointestinal symptoms. The study found that SIBO prevalence in SSc patients is 39.9%, with a 10-fold increased prevalence compared to controls. It also suggested that antimicrobial therapy should be considered for SSc patients with SIBO and diarrhea.

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

Development and Validation of a Patient-Reported Experience Measure for Gastrointestinal Endoscopy The Comprehensive Endoscopy Satisfaction Tool (CEST)

Marguerite J. Kutyla, Jessica J. McMaster, Adam Haig, Natasha Koloski, Luke Hourigan, Vera Meeusen, Ayesha Shah, Nicholas J. Talley, Michael P. Jones, Gerald J. Holtmann

Summary: This study aimed to develop and validate a patient-reported experience measure for GI endoscopy. The Comprehensive Endoscopy Satisfaction Tool captures relevant domains that influence the patient's experience and identifies factors that shape satisfaction. The tool was tested in a large number of patients and found to be valid and responsive.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

SYMPTOM CLUSTERS OUTSIDE THE ROME IV CONSENSUS CAN BE IDENTIFIED IN BOTH EASTERN AND WESTERN PATIENTS WITH A DISORDER OF GUT-BRAIN INTERACTION: PRELIMINARY RESULTS OF AN ONGOING INTERNATIONAL MULTICENTER STUDY

Esther Colomier, Lieselot Holvoet, Florencia Carbone, Kee-Huat Chuah, Sanjiv Mahadeva, Kewin Siah, Gerald J. Holtmann, Hidekazu Suzuki, Takashi Ueda, Magnus Simren, Kok-Ann Gwee, Jan F. Tack

GASTROENTEROLOGY (2022)

Article Rheumatology

Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity

P. R. Sternes, L. Brett, J. Phipps, F. Ciccia, T. Kenna, E. de Guzman, K. Zimmermann, M. Morrison, G. Holtmann, E. Klingberg, D. Mauro, C. McIvor, H. Forsblad-d'Elia, M. A. Brown

Summary: The gut microbiomes of AS and AS-IBD patients are different from IBD patients and healthy controls, indicating a distinct role of the gut in driving AS compared with IBD. However, the presence of potentially pathogenic genera shared between both diseases suggests a common microbial trigger of disease.

ARTHRITIS RESEARCH & THERAPY (2022)

No Data Available